Find out how different vaccines for the coronavirus cause your body to create antibodies that fight the virus.

This article originally appeared on the Bloomberg School of Public Health website. An mRNA flu vaccine is on its way. On Aug. 5, the U.S. Food and Drug Administration approved Moderna's mFLUSIVA, the ...

Moderna’s mFlusiva is the seasonal influenza shot that replaces the traditional egg-grown or cell-grown virus protein with a ...

For some older adults, the flu vaccine could look a little different this year. In August, the U.S. Food and Drug ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Malignant melanoma (cancer of the skin or mucous membranes), developed at the expense of ...

The U.S. Food and Drug Administration has approved a new flu vaccine, Moderna's mFlusiva, marking the public release of the first non-COVID-related mRNA vaccine in the U.S. Moderna's vaccine was ...

The Independent and Yahoo will earn a commission from purchases made via links in this article. Pricing and availability are subject to change. A personalised vaccine given in combination with a drug ...

In this episode of Inside Family Medicine, host Michael Monroe speaks with AAFP Vaccine Science fellows Anne Schneider, DO, FAAFP, and Mina Saleem Khan, MD, FAAFP, about why mRNA vaccines matter and ...

Individualized vaccines are built from resected tumor, using analytics to prioritize neoantigens most likely to be immunogenic, then encoding these targets into an mRNA construct tailored to each ...

An estimated 2.1 million new cancer cases will be diagnosed in the United States this year and an estimated 626 thousand will die, according to the American Cancer Society. However, there may be hope ...

Share on Pinterest Subtle differences in immune system reactions may explain why some people get more serious side effects ...

The personalized mRNA shot teaches the body to attack a patient’s specific melanoma cells A new vaccine could soon protect patients from returning skin cancer. In a large clinical trial, patients with ...